1 min read
Add as a preferred source on Google

ORIC Filing Lists -$0.38 Per-Share Loss for June Quarter

The Aug. 3 filing gave the same net loss per share for basic and diluted calculations for the quarter ended June 30, 2026.

NO STORY 관련 이미지 / TokenPost.ai
NO STORY 관련 이미지 / TokenPost.ai

ORIC Pharmaceuticals’ quarterly filing dated Aug. 3 lists net loss per share of -$0.38, both basic and diluted, for the quarter ended June 30, 2026.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…